To include your compound in the COVID-19 Resource Center, submit it here.

TroVax: Phase II started

Oxford BioMedica said researchers at Cardiff University (Cardiff, U.K.) began the open-label,

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE